ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management
Authors:
Abdelmalek Mouazer,
Romain Léguillon,
Nada Boudegzdame,
Thibaud Levrard,
Yoann Le Bars,
Christian Simon,
Brigitte Séroussi,
Julien Grosjean,
Romain Lelong,
Catherine Letord,
Stéfan Darmoni,
Matthieu Schuers,
Karima Sedki,
Sophie Dubois,
Hector Falcoff,
Rosy Tsopra,
Jean-Baptiste Lamy
Abstract:
Background: Polypharmacy, i.e. taking five drugs or more, is both a public health and an economic issue. Medication reviews are structured interviews of the patient by the community pharmacist, aiming at optimizing the drug treatment and deprescribing useless, redundant or dangerous drugs. However, they remain difficult to perform and time-consuming. Several clinical decision support systems were…
▽ More
Background: Polypharmacy, i.e. taking five drugs or more, is both a public health and an economic issue. Medication reviews are structured interviews of the patient by the community pharmacist, aiming at optimizing the drug treatment and deprescribing useless, redundant or dangerous drugs. However, they remain difficult to perform and time-consuming. Several clinical decision support systems were developed for hel** clinicians to manage polypharmacy. However, most were limited to the implementation of clinical practice guidelines. In this work, our objective is to design an innovative clinical decision support system for medication reviews and polypharmacy management, named ABiMed.
Methods: ABiMed associates several approaches: guidelines implementation, but the automatic extraction of patient data from the GP's electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics. We performed an ergonomic assessment and qualitative evaluations involving pharmacists and GPs during focus groups and workshops.
Results: We describe the proposed architecture, which allows a collaborative multi-user usage. We present the various screens of ABiMed for entering or verifying patient data, for accessing drug knowledge (posology, adverse effects, interactions), for viewing STOPP/START rules and for suggesting modification to the treatment. Qualitative evaluations showed that health professionals were highly interested by our approach, associating the automatic guidelines execution with the visual presentation of drug knowledge.
Conclusions: The association of guidelines implementation with visual presentation of knowledge is a promising approach for managing polypharmacy. Future works will focus on the improvement and the evaluation of ABiMed.
△ Less
Submitted 13 December, 2023;
originally announced December 2023.
A generic system for critiquing physicians' prescriptions: usability, satisfaction and lessons learnt
Authors:
Jean-Baptiste Lamy,
Vahid Ebrahiminia,
Brigitte Seroussi,
Jacques Bouaud,
Christian Simon,
Madeleine Favre,
Hector Falcoff,
Alain Venot
Abstract:
Clinical decision support systems have been developed to help physicians to take clinical guidelines into account during consultations. The ASTI critiquing module is one such systems; it provides the physician with automatic criticisms when a drug prescription does not follow the guidelines. It was initially developed for hypertension and type 2 diabetes, but is designed to be generic enough for a…
▽ More
Clinical decision support systems have been developed to help physicians to take clinical guidelines into account during consultations. The ASTI critiquing module is one such systems; it provides the physician with automatic criticisms when a drug prescription does not follow the guidelines. It was initially developed for hypertension and type 2 diabetes, but is designed to be generic enough for application to all chronic diseases. We present here the results of usability and satisfaction evaluations for the ASTI critiquing module, obtained with GPs for a newly implemented guideline concerning dyslipaemia, and we discuss the lessons learnt and the difficulties encountered when building a generic DSS for critiquing physicians' prescriptions.
△ Less
Submitted 3 December, 2013;
originally announced December 2013.
